Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
ARAV similar filings
- 4 Jan 22 Entry into a Material Definitive Agreement
- 12 Nov 21 7 of 16 (44%) patients achieved best overall response of partial response
- 9 Nov 21 3 of 5 (60%) patients achieved a partial response All 5 patients treated demonstrated tumor decrease from baseline
- 28 Oct 21 Aravive Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
- 10 Sep 21 Submission of Matters to a Vote of Security Holders
- 9 Aug 21 Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 for the Treatment of Pancreatic Adenocarcinoma
- 5 Aug 21 Aravive Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
Filing view
External links